Julia May

Ms. Julia May

Robert H Lurie Comprehensive Cancer Center
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Julia MayJulia May
Julia May
EKElizabeth Klass
Elizabeth Klass
KDKristina Davis
Kristina Davis
TPTimothy Pearman
Timothy Pearman
SRSteven Rittmeyer
Steven Rittmeyer
BHBrian Hitsman
Brian Hitsman
Tobacco use negatively impacts cancer treatment outcomes, yet too few providers actively support their patients in quitting. Barriers to consistently addressing tobacco use and referring to treatment include time constraints and lack of knowledge surrounding treatment options. Patient Reported Outcomes (PRO) measurement is best practice in cancer care and has potential to help address these barriers to tobacco cessation treatment. This descriptive program evaluation study reports preliminary results following implementation of a novel automated PRO tobacco use screener and referral system via the electronic health record (EHR) patient portal (MyChart) that was developed and implemented as a part of a population-based tobacco treatment program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Between 25 June 2019 and 6 April 2020, 4589 unique patients completed the screener and 164 (3.6%) unique patients screened positive for recent (past month) cigarette smoking. All patients who screened positive were automatically referred to a smoking cessation treatment program integrated within the Lurie Cancer Center, and 71 (49.7%) patients engaged in treatment, as defined by completing at least one behavioral counseling session. Preliminary results indicate that the PRO/MyChart system may improve smoker identification and increase offering of treatment and, despite the “cold call” following a positive screen, may result in a treatment engagement rate that is higher than rates of treatment engagement previously documented in oncology settings. Longer term evaluation with formal statistical testing is needed before drawing conclusions regarding effectiveness, but PRO measurement via the EHR patient portal may serve a potentially important role in a multi-component approach to reaching and engaging cancer patients in comprehensive tobacco cessation treatment.

2 April 2023 in Skin Research and Technology
Verified
Journal Article
Open access
JLJenna Lee
Jenna Lee
JBJuliana Benavides
Juliana Benavides
RMRayyan Manwar
Rayyan Manwar
CPCarolina Puyana
Carolina Puyana
Julia MayJulia May
Julia May
KAKamran Avanaki
Kamran Avanaki
Background: Phacomatosis pigmentokeratotica (PPK) is a distinct and rare type of epidermal nevus syndrome characterized by coexisting nonepidermolytic organoid sebaceous nevus (SN) with one or more speckled lentiginous nevi (SLN). Atypical nevi including compound Spitz and compound dysplastic may manifest within regions of SLN. Patients with PPK, or similar atypical nevus syndromes, may be subject to a significant lifetime number of biopsies, leading to pain, scarring, anxiety, financial burden, and decreased quality of life. The current literature includes case reports, genetics, and associated extracutaneous symptoms of PPK, but use of noninvasive imaging techniques have not been explored. We aim to investigate the value of high‐frequency ultrasound (HFUS) and optical coherence tomography (OCT) in discriminating morphological features of pigmented lesions and nevus sebaceous within one patient with PPK. Materials and methods: Two modalities, (1) HFUS imaging, based on acoustic properties and (2) OCT imaging, based on optical properties, were used to image a patient with PPK. Benign pigmented lesions, which may raise clinical suspicion for significant atypia, and nevus sebaceous, were selected on different areas of the body to be studied. Results: Five pigmented lesions and one area of nevus sebaceous were imaged and analyzed for noninvasive features. Distinct patterns of hypoechoic features were seen on HFUS and OCT. Conclusion: HFUS provides a deep view of the tissue, with ability to differentiate gross structures beneath the skin. OCT provides a smaller penetration depth and a higher resolution. We have described noninvasive features of atypical nevi and nevus sebaceous on HFUS and OCT, which indicate benign etiology.

3 March 2022
Verified
Conference Paper
Open access
CLChieh-Hsi Lin
Chieh-Hsi Lin
ARAli Rajabi-Estarabadi
Ali Rajabi-Estarabadi
Julia MayJulia May
Julia May
YPYanzhen Pang
Yanzhen Pang
MTMaria Tsoukas
Maria Tsoukas
KAKamran Avanaki
Kamran Avanaki
SPIE Digital Library Proceedings

4 January 2021 in Oncology Nursing Forum
Verified
Journal Article
Closed access
PDF file
Julia MayJulia May
Julia May
NJNancy C. Jao
Nancy C. Jao
KMKristen McCarter
Kristen McCarter
EKElizabeth Klass
Elizabeth Klass
TPTimothy Pearman
Timothy Pearman
BHBrian Hitsman
Brian Hitsman
To determine whether health-related quality of life (HRQOL) among individuals with cancer is undermined by smoking cessation treatment involving varenicline. Participants (N = 103) were daily smokers with cancer (up to five years postdiagnosis) who completed a placebo-controlled trial of standard versus extended duration varenicline. For this secondary study, participants were selected based on having completed the SF-12® at weeks 0, 1, 12, and 24. Using separate repeated measures multivariate analysis of variance, change in SF-12 scores was evaluated by time and by cancer treatment, varenicline duration, and quit status at week 24. There was no change in any of the three HRQOL scores by time or by cancer treatment status, varenicline duration, or quit status. Average emotional HRQOL score across time was significantly higher for quitters versus smokers. Varenicline, including long-term treatment, does not appear to adversely affect HRQOL, which is highly relevant to oncology nurses who are well positioned to assist with the pharmacologic treatment of tobacco dependence.

3 March 2022
Verified
Conference Paper
Open access
EBElnaz Babaee
Elnaz Babaee
BLBrandon Lukas
Brandon Lukas
Julia MayJulia May
Julia May
MCMostafa Charmi
Mostafa Charmi
KAKamran Avanaki
Kamran Avanaki
SPIE Digital Library Proceedings

13 April 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Julia MayJulia May
Julia May
AHAbbey Hanes
Abbey Hanes
JCJulia Chapin
Julia Chapin
SDSamantha Dumitrescu
Samantha Dumitrescu
VJVaruni Jamburuthugoda
Varuni Jamburuthugoda